fluorobenzenes has been researched along with Acute Kidney Failure in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 24 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dupre, TV; Jenkins, DP; Muise-Helmericks, RC; Schnellmann, RG | 1 |
| Dormuth, CR; Ernst, P; Garg, AX; Hemmelgarn, BR; James, MT; Lafrance, JP; Levy, A; Paterson, JM; Raymond, CB; Teare, GF | 1 |
| Roberts, A | 1 |
| Briguori, C; Marenzi, G | 1 |
| Campese, VM | 1 |
| Bellandi, F; Colonna, G; Di Sciascio, G; Grieco, D; Leoncini, M; Maioli, M; Patti, G; Toso, A | 1 |
| Garg, AX; Molnar, AO | 1 |
| Beeson, CC; Garrett, SM; Schnellmann, RG; Whitaker, RM | 1 |
| Han, Y | 1 |
| Cecere, N; Jadoul, M; Labriola, L | 1 |
| Ball, T; McCullough, PA | 1 |
| Badia, T; Bellandi, F; Leoncini, M; Maioli, M; Toso, A; Tropeano, F; Villani, S | 1 |
| Bellandi, F; Di Vincenzo, E; Leoncini, M; Maioli, M; Toso, A; Tropeano, F; Villani, S | 1 |
| Bailey, DG; Dixon, S; Fleet, JL; Gandhi, S; Garg, AX; Gomes, T; Juurlink, D; Kim, R; Li, DQ; Mamdani, M; McArthur, E; Shariff, SZ | 1 |
| Abaci, O; Arat Ozkan, A; Baydar, O; Cetinkal, G; Gurmen, T; Kaya, A; Kocas, C; Sukru Karaca, O | 1 |
| Fujiwara, W; Hayashi, M; Ito, T; Izawa, H; Kamada, T; Mukaide, D; Ozaki, Y; Sugishita, Y; Yokoi, H; Yoshikawa, D; Yoshinaga, M | 1 |
| Cao, XB; Chen, YD; Deng, J; Han, YL; Hu, TH; Jing, QM; Li, J; Li, Y; Liu, HW; Ma, YY; Tao, GZ; Wang, B; Wang, G; Wang, XZ; Xu, K; Zhang, J | 1 |
| Lewicki, M; Ng, I; Schneider, AG | 1 |
| Hu, YZ; Wu, YX; Yang, Y | 1 |
| E Madias, J | 1 |
| Buyukhatipoglu, H; Dag, OF; Guntekin, U; Kirhan, I; Sezen, Y | 1 |
| García Rodríguez, LA; Herings, R; Johansson, S | 1 |
| Dodiya, H; Goswami, SS; Jain, M | 1 |
| Amorós, F; Enríquez, R; Martínez-López, D; Millán, I; Redondo-Pachón, MD; Sirvent, AE | 1 |
| Davidson, MH | 1 |
| Arendt, CJ; Eggert, CH; Ireland, JH; Williams, AW | 1 |
| Goettsch, WG; Heintjes, EM; Herings, RM; Johansson, S; Kastelein, JJ; Rabelink, TJ | 1 |
7 review(s) available for fluorobenzenes and Acute Kidney Failure
| Article | Year |
|---|---|
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.
Topics: Acute Kidney Injury; Adult; Aged; Atorvastatin; British Columbia; Cohort Studies; Confidence Intervals; Databases, Factual; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorobenzenes; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Incidence; Logistic Models; Male; Middle Aged; Odds Ratio; Patient Safety; Pyrimidines; Pyrroles; Retrospective Studies; Risk Assessment; Rosuvastatin Calcium; Simvastatin; Sulfonamides; United Kingdom; United States | 2013 |
Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs.
Topics: Acute Kidney Injury; Atorvastatin; Disease Progression; Dyslipidemias; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Kidney; Kidney Diseases; Male; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Rosuvastatin Calcium; Sulfonamides | 2014 |
Statins for the prevention of contrast-induced acute kidney injury.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Albuminuria; Contrast Media; Coronary Angiography; Creatinine; Diabetes Complications; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inactivation, Metabolic; Kidney Tubules; Lipoproteins; Meta-Analysis as Topic; Muscle Cells; Percutaneous Coronary Intervention; Pyrimidines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Renal Replacement Therapy; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides | 2014 |
HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.
Topics: Acute Kidney Injury; Adult; Atorvastatin; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Coronary Artery Bypass; Creatinine; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Renal Replacement Therapy; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2015 |
Rosuvastatin Treatment for Preventing Contrast-Induced Acute Kidney Injury After Cardiac Catheterization: A Meta-Analysis of Randomized Controlled Trials.
Topics: Acute Kidney Injury; Cardiac Catheterization; Cardiovascular Diseases; Contrast Media; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides | 2015 |
Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins.
Topics: Acute Kidney Injury; Chemical and Drug Induced Liver Injury; Databases, Factual; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; International Cooperation; Male; Middle Aged; Muscular Diseases; Pharmacoepidemiology; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2010 |
Rosuvastatin safety: lessons from the FDA review and post-approval surveillance.
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Biomarkers; Cholesterol, LDL; Creatine Kinase; Creatine Kinase, MM Form; Drug Approval; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Incidence; Isoenzymes; Kidney Tubules; Muscular Diseases; Product Surveillance, Postmarketing; Proteinuria; Pyridines; Pyrimidines; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides | 2004 |
4 trial(s) available for fluorobenzenes and Acute Kidney Failure
| Article | Year |
|---|---|
Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Cardiotonic Agents; Clopidogrel; Contrast Media; Coronary Angiography; Creatine Kinase, MB Form; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardium; Necrosis; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ticlopidine; Treatment Outcome; Troponin I | 2014 |
Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Chi-Square Distribution; Contrast Media; Coronary Angiography; Creatinine; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Platelet Aggregation Inhibitors; Protective Factors; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome | 2014 |
Impact of Rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Female; Fluorobenzenes; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Prognosis; Pyrimidines; Retrospective Studies; Risk Factors; Rosuvastatin Calcium; Sulfonamides | 2015 |
Short-term rosuvastatin treatment for the prevention of contrast-induced acute kidney injury in patients receiving moderate or high volumes of contrast media: a sub-analysis of the TRACK-D study.
Topics: Acute Kidney Injury; Aged; Contrast Media; Female; Fluorobenzenes; Humans; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2015 |
16 other study(ies) available for fluorobenzenes and Acute Kidney Failure
| Article | Year |
|---|---|
The 5-hydroxytryptamine receptor 1F stimulates mitochondrial biogenesis and angiogenesis in endothelial cells.
Topics: Acute Kidney Injury; Animals; Benzamides; Carbazoles; Cells, Cultured; Endothelial Cells; Fluorobenzenes; Kidney; Male; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Organelle Biogenesis; Piperidines; Pyridines; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin | 2019 |
Prevention: Rosuvastatin can prevent contrast-induced AKI.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Angiography; Contrast Media; Coronary Angiography; Diabetes Mellitus, Type 2; Female; Fluorobenzenes; Humans; Male; Platelet Aggregation Inhibitors; Pyrimidines; Renal Insufficiency, Chronic; Sulfonamides | 2013 |
[The PRATO-ACS study].
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Contrast Media; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides | 2013 |
Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Atorvastatin; Contrast Media; Disease-Free Survival; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Percutaneous Coronary Intervention; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides | 2014 |
ACP Journal Club. Early high-dose rosuvastatin prevented contrast-induced acute kidney injury in non-ST-elevation ACS.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Contrast Media; Coronary Angiography; Female; Fluorobenzenes; Humans; Male; Platelet Aggregation Inhibitors; Pyrimidines; Sulfonamides | 2014 |
Agonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injury.
Topics: Acute Kidney Injury; Animals; Benzamides; Carbazoles; DNA, Mitochondrial; Electron Transport Complex IV; Female; Fluorobenzenes; Indoles; Kidney; Male; Mice; Mice, Inbred C57BL; Mitochondria; Oxidative Phosphorylation; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rabbits; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; Reperfusion Injury; Serotonin Receptor Agonists; Transcription Factors | 2014 |
Reply: Intravenous hydration (with or without rosuvastatin) should remain the cornerstone of the prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
Topics: Acute Kidney Injury; Angiography; Contrast Media; Diabetes Mellitus, Type 2; Female; Fluorobenzenes; Humans; Male; Pyrimidines; Renal Insufficiency, Chronic; Sulfonamides | 2014 |
Intravenous hydration (with or without rosuvastatin) should remain the cornerstone of the prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
Topics: Acute Kidney Injury; Angiography; Contrast Media; Diabetes Mellitus, Type 2; Female; Fluorobenzenes; Humans; Male; Pyrimidines; Renal Insufficiency, Chronic; Sulfonamides | 2014 |
Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Clarithromycin; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Fatty Acids, Monounsaturated; Female; Fluorobenzenes; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperkalemia; Indoles; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Pravastatin; Pyrimidines; Retrospective Studies; Rhabdomyolysis; Rosuvastatin Calcium; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfonamides | 2015 |
Takotsubo cardiomyopathy with involvement of delayed-onset rhabdomyolysis and acute kidney injury after rosuvastatin treatment.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Aged; Diagnosis, Differential; Electrocardiography; Fluorobenzenes; Heart Ventricles; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides; Takotsubo Cardiomyopathy; Treatment Outcome; Withholding Treatment | 2015 |
Persistent Excessive Electrocardiogram ST-segment Elevation in a Patient with a Takotsubo Syndrome: What Could be the Cause?
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rhabdomyolysis; Sulfonamides; Takotsubo Cardiomyopathy | 2016 |
Acute renal failure with the combined use of rosuvastatin and fenofibrate.
Topics: Acute Kidney Injury; Adult; Drug Interactions; Female; Fenofibrate; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2010 |
Renal toxicity of lisinopril and rosuvastatin, alone and in combination, in Wistar rats.
Topics: Acute Kidney Injury; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Clusterin; Drug Combinations; Female; Fluorobenzenes; Kidney Tubules, Proximal; Lisinopril; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides | 2011 |
Rhabdomyolysis and acute renal failure following hard physical activity in a patient treated with rosuvastatin.
Topics: Acute Kidney Injury; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Physical Exertion; Pyrimidines; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides | 2012 |
Rhabdomyolysis with cardiac involvement and acute renal failure in a patient taking rosuvastatin and fenofibrate.
Topics: Acute Kidney Injury; Female; Fenofibrate; Fluorobenzenes; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Middle Aged; Pyrimidines; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides | 2005 |
Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Male; Middle Aged; Muscular Diseases; Pyrimidines; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides | 2006 |